Biblio
Export 166 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is K [Clear All Filters]
“Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1129-1135, 2017.
, “Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.”, J Alzheimers Dis, vol. 81, no. 1, pp. 189-199, 2021.
, “The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1253-1273, 2018.
, “Factors Underpinning Caregiver Burden in Frontotemporal Dementia Differ in Spouses and their Children.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1109-1117, 2017.
, “[18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1595-1607, 2018.
, “Linking Air Pollution Exposure to Blood-Based Metabolic Features in a Community-Based Aging Cohort with and without Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1025-1040, 2023.
, “Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1349-1372, 2017.
, “Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1815-1826, 2018.
, “Consecutive Analysis of BACE1 Function on Developing and Developed Neuronal Cells.”, J Alzheimers Dis, vol. 56, no. 2, pp. 641-653, 2017.
, “A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 64, no. 1, pp. 1-16, 2018.
, “Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost.”, J Alzheimers Dis, vol. 49, no. 2, pp. 277-85, 2016.
, “Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1169-77, 2016.
, “Therapeutics of Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1049-1069, 2017.
, “PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1563-76, 2016.
, “Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials.”, J Alzheimers Dis, vol. 54, no. 3, pp. 879-889, 2016.
, “Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.”, J Alzheimers Dis, vol. 53, no. 2, pp. 547-56, 2016.
, “Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1191-1205, 2018.
, “Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility.”, J Alzheimers Dis, vol. 83, no. 2, pp. 879-887, 2021.
, “Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.”, Lancet Neurol, vol. 10, no. 2, pp. 187-98, 2011.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population.”, J Alzheimers Dis, vol. 55, no. 1, pp. 359-369, 2017.
, “Association of Serum Vitamin D with the Risk of Incident Dementia and Subclinical Indices of Brain Aging: The Framingham Heart Study.”, J Alzheimers Dis, vol. 51, no. 2, pp. 451-61, 2016.
, “Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1385-1393, 2016.
, “Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.”, J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
, “Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.”, J Alzheimers Dis, vol. 60, no. 2, pp. 721-731, 2017.
,